查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1781193

兹卡病毒检测市场：全球产业分析与市场规模、份额、成长、趋势与预测（2025-2032 年）

Zika Virus Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 192 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球兹卡病毒检测市场的全面分析报告。该报告对关键市场动态进行了全面评估，包括市场驱动因素、趋势、机会和挑战，并深入分析了市场结构。本报告为寻求应对感染疾病诊断领域变化并充分利用市场潜力的行业相关人员提供了策略指南。

关键见解

  • 兹卡病毒检测市场规模（2025年）：510万美元
  • 市场规模预测（以金额为准，2032 年）：690 万美元
  • 全球市场成长率（2025-2032年复合年增长率）：4.3%

兹卡病毒检测市场 - 分析范围

兹卡病毒检测市场涵盖各种用于检测兹卡病毒的诊断技术，包括分子检测和血清学检测。这些检测对于早期诊断、产前护理和疫情应对至关重要。由于人们健康意识的提高、诊断技术的进步以及全球卫生组织为提高疾病检测能力所做的持续努力，该市场正在稳步增长。由于人们对出生缺陷以及病毒对孕妇影响的持续担忧，对准确且便捷的检测的需求仍然很高。

市场成长动力：

兹卡病毒检测市场的成长得益于人们日益意识到该病毒对健康的严重影响，尤其是在怀孕期间。国际旅行的增加和气候变迁有利于携带兹卡的蚊子的传播，从而推动了对可靠检测的需求。快速分子检测和改进的血清学检测等诊断技术的进步显着提高了检测的速度和准确性。此外，全球卫生部门的资金支持和积极的政府卫生政策在扩大全球检测基础设施和能力方面发挥关键作用。

市场限制：

儘管市场展现出成长潜力，但某些因素正在限制其扩张。近年来，兹卡病毒报告病例显着下降，降低了检测的紧迫性，尤其是在非疫区。在低收入国家，检测费用高昂，尤其是分子诊断费用高昂，是个障碍。农村地区医疗基础设施不足和训练有素的专业人员缺乏也限制了兹卡检测的广泛应用。此外，来自多疾病诊断平台的竞争以及医疗保健重点的转变，可能会将焦点从兹卡专项检测服务转移。

市场机会：

开发针对偏远和服务欠缺地区的便携式、快速且经济高效的检测解决方案存在巨大的机会。对孕产妇健康和产前筛检计画的日益关注将推动兹卡病毒诊断的强劲需求。即时检测和可同时检测多种感染的多重检测技术的进步也正在开闢新的应用领域。新兴经济体代表着一个尚未开发的市场，其医疗保健投资不断增加，并得到了全球机构的支持。诊断公司与公共卫生机构之间的合作可以进一步提高检测的效用，并推动兹卡诊断的创新。

本报告回答的关键问题

  • 是什么推动了全球对兹卡病毒检测的需求？
  • 哪些测试和应用预计会达到最高成长？
  • 诊断创新如何影响兹卡检测市场？
  • 主要企业是谁？他们正在实施什么策略？
  • 哪些不同地区的趋势正在塑造兹卡病毒检测市场的未来？

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 抑制因素
    • 机会
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长预测
  • COVID-19影响分析
  • 预测因子：相关性和影响力

第三章 加值分析

  • 工具采用分析
  • 监管状况
  • 价值链分析
  • PESTLE分析
  • 波特五力分析

第四章 价格分析（2024年）

  • 主要亮点
  • 影响实施成本的关键因素
  • 定价分析：按应用

第五章全球兹卡病毒检测市场展望

  • 主要亮点
    • 市场规模预测（以数量为基础）
    • 市场规模及年成长率（以金额为准）
    • 绝对的商机
  • 市场规模分析与预测（以金额为准）
    • 历史市场规模分析（以金额为准，2019-2024）
    • 当前市场规模分析与预测（以金额为准，2025-2032）
  • 全球兹卡病毒检测市场展望（按检测类型）
    • 引言/主要发现
    • 历史市场规模分析：按测试类型（价值和数量，2019-2024）
    • 按测试类型分類的当前市场规模分析和预测（价值和数量，2025-2032）
      • 分子检测
      • 血清学检测
    • 按测试类型分析市场吸引力
  • 全球兹卡病毒检测市场应用前景
    • 引言/主要发现
    • 历史市场规模分析：按应用（价值和数量，2019-2024）
    • 当前市场规模分析及应用预测（价值和数量，2025-2032）
      • 临床试验
      • 血液检查
      • 研究与开发
      • 产前检查
    • 市场吸引力分析：按应用
  • 全球兹卡病毒检测市场前景（按最终用户）
    • 引言/主要发现
    • 按最终用户分類的历史市场规模分析（价值和数量，2019-2024 年）
    • 当前市场规模分析及最终用户预测（价值和数量，2025-2032）
      • 医院和诊所
      • 诊断实验室
      • 血库
      • 分析实验室
      • 公共卫生机构
    • 最终用户的市场吸引力分析

6. 全球兹卡病毒检测市场（按地区）展望

  • 主要亮点
  • 历史市场规模分析：按地区（价值和数量，2019-2024）
  • 当前市场规模分析及各地区预测（价值和数量，2025-2032）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：地区

7. 北美寨兹卡病毒检测市场展望

8. 欧洲兹卡病毒检测市场展望

9. 东亚兹卡兹卡病毒检测市场展望

10. 南亚及大洋洲兹卡病毒检测市场展望

11. 拉丁美洲兹卡病毒检测市场展望

12. 中东和非洲兹卡病毒检测市场展望

第十三章竞争格局

  • 市场占有率分析（2024年）
  • 市场结构
    • 竞争强度图：按市场
    • 竞争对手仪表板
  • 公司简介（详情：概述、财务状况、策略、最新发展）
    • Abbott Laboratories
    • Altona Diagnostics GmbH
    • Chembio Diagnostics Inc.
    • ELITechGroup-A Bruker Company
    • F. Hoffmann La-Roche AG
    • Genekam Biotechnology AG
    • DiaSorin（Luminex Corporation）
    • Novacyt Group

第十四章 附录

  • 分析方法
  • 分析假设
  • 首字母缩写和简称
简介目录
Product Code: PMRREP35097

Persistence Market Research has recently published an in-depth report on the global Zika Virus Testing Market, offering detailed insights into current trends, growth drivers, market challenges, and emerging opportunities. This report serves as a strategic guide for industry stakeholders looking to navigate the evolving landscape of infectious disease diagnostics and capitalize on market potential.

Key Insights:

  • Zika Virus Testing Market Size (2025E): US$ 5.1 Mn
  • Projected Market Value (2032F): US$ 6.9 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.3%

Zika Virus Testing Market - Report Scope:

The Zika virus testing market involves a range of diagnostic techniques used to detect the Zika virus, including molecular and serological tests. These tests are crucial for early diagnosis, prenatal care, and outbreak control. The market is witnessing steady growth, driven by rising health awareness, technological advancements in diagnostics, and ongoing efforts by global health organizations to improve disease detection capabilities. As concerns around birth defects and the virus's impact on pregnant women continue, the need for accurate and accessible testing remains high.

Market Growth Drivers:

The growth of the Zika virus testing market is supported by increasing awareness of the virus's severe health implications, especially during pregnancy. Growing international travel and climate changes have contributed to the wider spread of Zika-carrying mosquitoes, boosting the demand for reliable testing. Technological advancements in diagnostics, such as rapid molecular testing and improved serological assays, have significantly enhanced detection speed and accuracy. Additionally, funding from global health authorities and proactive government health policies are playing a vital role in expanding testing infrastructure and capabilities worldwide.

Market Restraints:

While the market shows growth potential, certain factors are limiting its expansion. A notable decline in reported Zika cases in recent years has reduced testing urgency, particularly in non-endemic regions. High testing costs, especially for molecular diagnostics, pose a barrier in low-income countries. Inadequate healthcare infrastructure and a lack of trained professionals in rural areas also restrict the widespread adoption of Zika testing. Furthermore, competition from multi-disease diagnostic platforms and shifting healthcare priorities may divert focus away from Zika-specific testing services.

Market Opportunities:

Significant opportunities exist in the development of portable, rapid, and cost-effective testing solutions tailored for remote and underserved regions. The growing focus on maternal health and prenatal screening programs presents strong demand for Zika virus diagnostics. Advances in point-of-care testing and multiplex assays that detect multiple infections simultaneously are also opening up new applications. Emerging economies, with increased healthcare investment and support from global agencies, represent untapped markets. Collaborations between diagnostic companies and public health organizations can further enhance test availability and drive innovation in Zika diagnostics.

Key Questions Answered in the Report:

  • What factors are contributing to the global demand for Zika virus testing?
  • Which testing methods and applications are expected to see the highest growth?
  • How are diagnostic innovations influencing the Zika testing market?
  • Who are the major players, and what strategies are they implementing?
  • What regional developments are shaping the future of the Zika virus testing market?

Competitive Intelligence and Business Strategy:

Leading companies in the Zika virus testing space, including Abbott Laboratories, Chembio Diagnostics Inc., and Roche, are prioritizing the development of rapid, user-friendly, and affordable diagnostic kits. These players are expanding their market reach through strategic partnerships with public health organizations and increased presence in emerging markets. Emphasis is placed on creating scalable solutions that can be deployed during outbreaks or used in routine prenatal screening. By enhancing product efficiency and focusing on underserved regions, key companies are positioning themselves to lead the market as global health priorities evolve.

Companies Covered in This Report:

  • Abbott Laboratories
  • Altona Diagnostics GmbH
  • Chembio Diagnostics Inc.
  • ELITechGroup
  • Hoffmann-La Roche Ltd
  • Genekam
  • DiaSorin (Luminex Corporation)
  • Novacyt Group

Market Segmentation

By Test Type

  • Molecular Testing
  • Serological Testing

By Application

  • Clinical Testing
  • Blood Screening
  • Research and Development
  • Prenatal Testing

By End-use

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Blood Banks
  • Research Institutes
  • Public Health Organizations

By Region

  • North America
  • Europe
  • East Asia
  • Middle East & Africa
  • Latin America
  • South Asia & Pacific

Table of Contents

1. Executive Summary

  • 1.1. Global Zika Virus Testing Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-economic Factors
    • 2.3.1. Global Sectoral Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Tool Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. PESTLE Analysis
  • 3.5. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Deployment Costs
  • 4.3. Pricing Analysis, By Application

5. Global Zika Virus Testing Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 5.3. Global Zika Virus Testing Market Outlook: Test Type
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Test Type, 2019-2024
    • 5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
      • 5.3.3.1. Molecular Testing
      • 5.3.3.2. Serological Testing
    • 5.3.4. Market Attractiveness Analysis: Test Type
  • 5.4. Global Zika Virus Testing Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
    • 5.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 5.4.3.1. Clinical Testing
      • 5.4.3.2. Blood Screening
      • 5.4.3.3. Research and Development
      • 5.4.3.4. Prenatal Testing
    • 5.4.4. Market Attractiveness Analysis: Application
  • 5.5. Global Zika Virus Testing Market Outlook: End User
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 5.5.3.1. Hospitals and Clinics
      • 5.5.3.2. Diagnostic Laboratories
      • 5.5.3.3. Bloods Banks
      • 5.5.3.4. Research Institutes
      • 5.5.3.5. Public Health Organizations
    • 5.5.4. Market Attractiveness Analysis: End User

6. Global Zika Virus Testing Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2024
  • 6.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Zika Virus Testing Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Test Type
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
    • 7.4.1. Molecular Testing
    • 7.4.2. Serological Testing
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Clinical Testing
    • 7.5.2. Blood Screening
    • 7.5.3. Research and Development
    • 7.5.4. Prenatal Testing
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Hospitals and Clinics
    • 7.6.2. Diagnostic Laboratories
    • 7.6.3. Bloods Banks
    • 7.6.4. Research Institutes
    • 7.6.5. Public Health Organizations
  • 7.7. Market Attractiveness Analysis

8. Europe Zika Virus Testing Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Test Type
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
    • 8.4.1. Molecular Testing
    • 8.4.2. Serological Testing
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.5.1. Clinical Testing
    • 8.5.2. Blood Screening
    • 8.5.3. Research and Development
    • 8.5.4. Prenatal Testing
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Hospitals and Clinics
    • 8.6.2. Diagnostic Laboratories
    • 8.6.3. Bloods Banks
    • 8.6.4. Research Institutes
    • 8.6.5. Public Health Organizations
  • 8.7. Market Attractiveness Analysis

9. East Asia Zika Virus Testing Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Test Type
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
    • 9.4.1. Molecular Testing
    • 9.4.2. Serological Testing
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Clinical Testing
    • 9.5.2. Blood Screening
    • 9.5.3. Research and Development
    • 9.5.4. Prenatal Testing
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Hospitals and Clinics
    • 9.6.2. Diagnostic Laboratories
    • 9.6.3. Bloods Banks
    • 9.6.4. Research Institutes
    • 9.6.5. Public Health Organizations
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Zika Virus Testing Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Test Type
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
    • 10.4.1. Molecular Testing
    • 10.4.2. Serological Testing
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Clinical Testing
    • 10.5.2. Blood Screening
    • 10.5.3. Research and Development
    • 10.5.4. Prenatal Testing
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Hospitals and Clinics
    • 10.6.2. Diagnostic Laboratories
    • 10.6.3. Bloods Banks
    • 10.6.4. Research Institutes
    • 10.6.5. Public Health Organizations
  • 10.7. Market Attractiveness Analysis

11. Latin America Zika Virus Testing Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Test Type
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
    • 11.4.1. Molecular Testing
    • 11.4.2. Serological Testing
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Clinical Testing
    • 11.5.2. Blood Screening
    • 11.5.3. Research and Development
    • 11.5.4. Prenatal Testing
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Hospitals and Clinics
    • 11.6.2. Diagnostic Laboratories
    • 11.6.3. Bloods Banks
    • 11.6.4. Research Institutes
    • 11.6.5. Public Health Organizations
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Zika Virus Testing Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Test Type
    • 12.2.3. By Application
    • 12.2.4. By Application
    • 12.2.5. By End User
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Test Type, 2025-2032
    • 12.4.1. Molecular Testing
    • 12.4.2. Serological Testing
  • 12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 12.5.1. Clinical Testing
    • 12.5.2. Blood Screening
    • 12.5.3. Research and Development
    • 12.5.4. Prenatal Testing
  • 12.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 12.6.1. Hospitals and Clinics
    • 12.6.2. Diagnostic Laboratories
    • 12.6.3. Bloods Banks
    • 12.6.4. Research Institutes
    • 12.6.5. Public Health Organizations
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Abbott Laboratories
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Deployments
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Altona Diagnostics GmbH
    • 13.3.3. Chembio Diagnostics Inc.
    • 13.3.4. ELITechGroup - A Bruker Company
    • 13.3.5. F. Hoffmann La-Roche AG
    • 13.3.6. Genekam Biotechnology AG
    • 13.3.7. DiaSorin (Luminex Corporation)
    • 13.3.8. Novacyt Group

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations